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Abstract 
 
Background: Complementary and alternative medicines (CAM) are increasingly popular globally with frequent use 
amongst patients with atopic eczema (AE). Despite increased AE prevalence in South Africa (SA), no local data on 
CAM-use for this disease exists. 
Methods: A cross-sectional study utilizing a comprehensive questionnaire qualifying and quantifying CAM use in 
patients with AE. We interviewed 206 AE patients; 106 from a public hospital dermatology clinic and 100 from private 
dermatology practices in central Durban. One-way analysis of variance (ANOVA) compared means of continuous 
predictors across 3 or more groups. Differences in frequencies of categorical explanatory variables by CAM and AE 
were assessed using Pearson chi-square (χ2) test or Fishers exact test. 
Results:  There were 143 children, 63 adults; 163 females and 43 males. Races represented were Black (56%), Indian 
(33%), Coloured (6%) and White (4%). 135(66%) reported current or previous CAM use. Common reasons were 
family/friends’ recommendations (42%) and media-influence (23%). Frequently used CAMs were vitamins (35%), 
aromatherapy oils (27%), herbal creams (26%), traditional African medicines (23%) and homeopathy (19%). Non-
disclosure to the dermatologist was high (59%). Almost half (48%) said they were not questioned about CAM use. 
More Indian patients used CAM (p=0.001) and Muslims were most frequent CAM users (p=0.044). Although not 
statistically significant, the more educated and higher income bracket used CAM more. 28% felt CAM had fewer side-
effects, 28% felt it was safer than conventional medicine and 35% felt CAM was more natural. 
Conclusion: The detailed trends of CAM use by South Africans for AE is an important addition to the current 
literature. Dermatologists and healthcare professionals addressing patients with AE need to be more familiar with CAM 
types that patients may explore as this could impact on the overall clinical outcome. 
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Introduction 
 
Atopic eczema (AE), a chronic, relapsing disease, is the commonest inflammatory skin condition in children 
and adults (Deckers et al., 2012). A systematic review (SR) of epidemiological studies, revealed an increasing 
prevalence in Africa with approximate doubling of lifetime prevalence in South Africa (SA) (Deckers et al., 2012). 
Numerous studies have demonstrated the increased use of complementary and alternative medicine (CAM) amongst 
dermatological patients (Baron et al., 2005; Buchar et al., 2012; Eisenberg et al., 1998; Magin & Adams, 2007). Atopic 
eczema was reported to be the most frequent dermatological condition where CAM was sought (Baron et al., 2005; 
Bielory & Lupoli, 1999; Ernst, 2000). Several cross-sectional studies, in Ireland (Hughes et al., 2007), United Kingdom 
(Johnston et al., 2003), Korea, (Kim et al., 2013) United States (Simpson et al., 2003) and Norway (Jensen, 1990) have 
qualified and quantified CAM-use in AE.  
A prevalence-study of traditional medicine (TM) and CAM in the general SA-population, showed declines in TM-use 
but increased CAM-use over 13 years (Peltzer, 2009). Population and health facility-based surveys indicated that both 
play important roles in SA healthcare delivery, however, lack of data about the extent of CAM-use in varying 
conditions was reported (Peltzer, 2009). Other SA studies highlighting CAM’s popularity were amongst an Indian 
population (Singh et al., 2004) and in HIV patients (Peltzer et al., 2008).  
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We found no African studies that explored CAM-use in AE and thus devised a comprehensive questionnaire 
to quantify the extent of CAM-use, types utilized, influence of age, gender, race, socio-economic status and education 
level on CAM-use in AE. We believe ours is the first African study to provide this information within the context of 
AE. This study yields new insights beneficial to dermatologists, paediatricians, general practitioners (GPs), pharmacists 
and CAM practitioners that treat patients for AE.  
Studies in Africa that explored CAM-use in individuals afflicted with AE are scarce. We thus devised a 
comprehensive questionnaire to explore CAM-use within central Durban, South Africa. The objectives of this study 
were to determine the types of CAMs utilized and to quantify the extent of CAM-use in patients with AE. Furthermore, 
the demographic and socio-economic attributes were explored to determine their influence on CAM-use.  
 
Materials and Methods 
 
 This cross-sectional study comprised 206 patients selected from both the public and private sector to provide a 
broader demographic profile. The sample size was calculated based on population estimates from studies of AE 
patients attending public and private hospitals (Dlova et al., 2017; Dlova et al., 2015). These studies considered the 
number of AE patients attended to per month in both public and private sectors. By measuring the patient volume per 
month at these facilities, population estimates were achieved. Using a sample size calculator (with a 95% confidence 
level and a 5% margin of error) in consultation with a biostatistician, a sample of 206 patients was selected.  
A consecutive sampling method was implemented until the full sample size was reached. 
 
Location 
 
King Edward VIII Hospital (KEH) was the public health facility, where 106 patients were selected. This 
facility was chosen as it is largest teaching hospital and largest dermatology clinic in KwaZulu-Natal, South Africa. 
Five private dermatology practices in central Durban were selected by means of purposive sampling. These were 
selected based on proximity as well as the resident dermatologists’ willingness to allow the researchers to interview 
patients attending their respective practices. Amongst these private practices, 100 patients were selected.  
 
Inclusion Criteria 
 
Patients of all ages with an existing diagnosis of AE confirmed by a consulting dermatologist at the respective 
practices, who provided informed consent (themselves/parent/caregiver) were recruited.  
Public-patients were recruited over 3 months. Informed written consent was obtained from these patients and they were 
interviewed face to face. isiZulu being the main language of the predominantly Black population in KwaZulu-Natal, 
necessitated the presence of a translator. 
Patients attending private practices were asked by the consulting dermatologist if they were keen to participate in the 
study. Those that were agreeable provided contact details and were contacted and interviewed telephonically where a 
verbal consent was obtained. These patients were recruited over a period of 6 months. For children, the parent/primary 
caregiver was interviewed.  
 
Exclusion criteria  
 
 Patients with other types of eczema or where the diagnosis was not confirmed by the consulting dermatologist 
were excluded from the study.  
 
Questionnaire  
 
 The comprehensive questionnaire was developed with reference to several questionnaires used in international 
studies and was modified to suit the current context (Baron et al., 2005; Johnston et al., 2003; Kim et al., 2013). The 
questions created by these authors were used as a guideline which was further modified and adapted to suit the context 
of this study and location. The authors acknowledge the studies which assisted in the development of the questionnaire. 
The questionnaire was further reviewed by an expert research/clinical dermatologist and was then piloted amongst 10 
patients thus enabling us to address ambiguity and structure. The main themes of the questionnaire are summarised in 
Table 1. 
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Statistical Analysis 
 
Data were analysed using Stata 13.0 SE (StataCorp. 2013.Stata Statistical Software: Release 13. College 
Station, TX: StataCorp LP). Relationships between continuous predictors and CAM use were assessed using a standard 
t-test. One-way analysis of variance (ANOVA) was employed to compare means of continuous predictors across 3 or 
more groups. Differences in frequencies of categorical explanatory variables by CAM and AE were assessed using 
Pearson chi-square (χ2) test or Fishers exact test if an expected cell count contained fewer than 5 observations. A p-
value of <0.05 was deemed statistically significant. 
 
Ethics: The study was approved by the Biomedical Research Ethics Committee, University of KwaZulu-Natal 
(BE219/14). 
 
Results 
Demographics 
 
All 206 patients approached agreed to participate, yielding a 100% response-rate. There were 143 children and 
63 adults. Age categories ranged from <3 months to >50 years. Females comprised 79%(163) and males 21%(43). Race 
was predominantly Black, 116(56%), then 68(33%) Indian, 12(6%) Coloured, 9(4%) White and <1% Chinese. 
Amongst religious groups there were 141(68%) Christian, 33(16%) Muslim and 26(12%) Hindu. The remainder 6(3%) 
were atheist, agnostic or did not respond. Most had secondary schooling as their highest educational level 95(46%), 
61(30%) had college education, 20(10%) postgraduate qualifications, 21(10%) up to primary school and 9(4%) no 
schooling. Average gross monthly household incomes were: 49(24%) <R2000, 45(22%) R2000-R5000, 21(10%) 
R5000-R10000, 40(19%) R10000-R20000 and 44(21%) >R20000. Seven students and pensioners (3%) did not know 
their household-income. As anticipated, private patients were more educated with higher household incomes compared  
Table 1: Main Themes addressed in Study Questionnaire 
SECTION A  
 
Demographics 
Patient particulars, Practice attending for treatment, Gender, Religion, 
Race, Age of Patient/Care-giver, Level of Education, Average gross 
monthly household income 
 
 
 
 
 
 
 
 
SECTION B  
 
Treatment Management of Atopic Eczema 
Duration of disease, current dermatologist prescribed treatment e.g. steroid 
creams/tablets/syrup, antihistamines, immunosuppressant creams/tablets, 
emollients, moisturizers 
SECTION C 
 
CAM use and the Patient 
Current or Previous use of CAM, Patients familiarity and usage of the 
following CAMs: 
Herbal creams, Herbal tablets/capsules/powders/pellets, 
Chinese herbal medicines, Traditional Indian medicines (Ayuverdic) 
Traditional African medicines (Inyanga/Isangoma), Homeopathy 
Vitamin supplements, Acupuncture, Natural Health Supplements, 
Aromatherapy (massage oils),  
Reflexology, Reiki, Chiropractic, Other 
Duration of CAM use 
Disclosure/Non-disclosure of CAM use to dermatologist with reasons 
CAM use with/without conventional medicines 
Reasons for using CAM 
Patients Satisfaction of CAM use on eczema symptoms 
Reasons for not exploring CAM (where applicable) 
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to public patients (p<0.001).  196(95%) reported currently using topical steroids, 68(33%) systemic immune-
suppressants and 27(13%) systemic steroids.   
 
CAM-users 
 
The investigators considered a CAM-user to be any patient who has explored diverse medical and healthcare 
practices and products that are generally not considered part of conventional medicines or prescribed by conventional 
doctors for the treatment of AE. A large number of patients (135/206-66%) reported using CAM for AE. Of these, 
45(22%) were currently using CAM and 90(44%) had tried them previously. Of the 135 patients, 92 used CAM for 
their children and 43 for themselves. However, there was no significant difference in frequency of children CAM-users 
(92/143-64%) compared to adults (43/63-68%) (p=0.586). No significant difference was noted between male (30/43-
70%) or female (105/163-64%) CAM-users (p=0.511) and with respect to ages that explored CAM for themselves or 
their children (p=0.905). The age categories were notably wide-ranging and were: <30 years (51/75-68%), >50 years 
(15/22-68%), 41-50 years (29/45-64%) and 31-40 years (40/64-63%).  
Race and religion were both statistically significant predictors of CAM-use. More Indian patients used CAM, 
53/68(78%) compared to 8/12(67%) Coloured, 68/116(59%) Black and 5/9(56%) White patients (p=0.001). The 1 
Chinese patient was currently using CAM. More Muslims explored CAM, 28/33(85%) than 18/26(69%) Hindu and 
85/141(60%) Christian (p=0.044).  
Although more patients who attended college, 46/61(75%) or had postgraduate qualifications, 14/20(70%) 
used CAM, this was not statistically significant (p=0.302) compared to CAM-users with no schooling (6/9-67%), 
primary-school education (13/21-62%) or up to secondary-school (56/95-59%). 
Whilst there was no significant difference among monthly household-income levels with respect to CAM-use 
(p= 0.23), more patients with incomes of R5000-R10000 (16/21-76%) and R10000-R20000 (30/40-75%) used CAM. 
Among those with income >R20 000, 30/44(68%) were CAM-users. Fewer in the lower income bracket tried CAM 
(27/47-57% earning <R2000; 25/45-56% earning R2000-R5000). 
Of the 100 private-users, 69% used CAM and among 106 public-users, 62% (66/106) were CAM-users, 
however, no significant difference was noted between these (p=0.309).  
Results showed that long-time sufferers were more likely to use CAM (p<0.001). Amongst CAM-users, the 
mean duration of AE was 8.4yrs (SD=9.8) compared to non-users with mean duration of 4.1yrs (SD=4.9). 
The number that reported no CAM use was 71/206 (35%). Reasons provided were “belief that CAM does not 
work” (30/71-42%), “faith in conventional-medicines only” (23/71-32%), “fear of combining treatment types” (7/71-
10%) and 9/71(13%) felt “no reason to as their prescribed conventional medicines worked well”. The comment that 
“CAM was expensive” was reported by 6%(4/71) and 4%(3/71) had “no knowledge of them”. This equates to >100% 
as some provided several reasons. 
Demographics and characteristics of CAM-users are presented in Table 2. The various CAMs used and 
patients’ familiarity with them is reflected in Table 3. 
 
Table 2: Demographics and Characteristics of CAM users’ vs Total study population  
 Total Study Population 
n=206  
(100%) 
CAM Users 
n=135/206  
(66%) 
Gender  
Male 43 (21%)   30/135 (22%) 
Female 163 (79%) 105/135 (78%) 
Age Category 
Adult with AE 63 (31%) 43/135 (32%) 
Children with AE 143 (69%) 92/135 (68%) 
Highest frequency age range of adults with 
AE 
<30 [n=30(15%)] <30 [n=22(73%)] 
Highest frequency age range of children with 
AE 
2-5 years [n=39(27%)] Parents/care-givers are the 
decision-makers 
Race* 
Black African 116 (56%) 68/135 (50%) 
Indian 68 (33%) 53/135 (39%) 
Coloured  12 (6%) 8/135 (6%) 
White 9 (4%) 5/135 (4%) 
Asian 1 (0.5%) 1/135 (0.74%) 
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Religion* 
Christian 141 (68%) 85/135 (63%) 
Islam 33 (16%) 28/135 (21%) 
Hinduism 26 (13%) 18/135 (13%) 
No religious domination   6 (3%)   4/135 (3%) 
Education  
Postgraduate qualification 20 (10%) 14/135 (10%) 
College education 61 (30%) 46/135 (34%) 
Secondary School 95 (46%) 56/135 (41%) 
Primary School 21 (10%) 13/135 (10%) 
No school  9 (4%)  6/135 (4%) 
Monthly Household Income 
< R2000 49 (24%) 29/49 (59%) 
R2000-R5000 45 (22%) 25/45 (56%) 
R5000-R10 000 21 (10%) 16/21 (76%) 
R10000-R20 000 40 (19%) 30/40 (75%) 
>R20 000 44 (21%) 30/44 (68%) 
Unknown (student, pensioner) 7 (3%) 0 
Type of Facility attended 
Public  106 66/106 (49%) 
Private 100 69/100 (69%) 
Duration of AE* 4 years (SD=4,87) 8 years (SD=9,75) 
 
 
Familiarity and CAM choices 
 
Although vitamins were most frequently used, 38(52%) said they were not necessarily for eczema but for 
overall well-being in the hope that it would also help their skin. Vitamins specifically for AE were used by 35(48%),  
Table 3: Complementary Therapies Used for Atopic Eczema and Patients’ familiarity with them (of a sample of 
206 patients) 
Complementary Therapy Total Number 
Used  
Familiar but 
have not used  
Unfamiliar  
Vitamin supplements 73 (35%) 60 (29%) 73 (35%) 
Aromatherapy oils  55 (27%) 67 (33%) 84 (41%) 
Herbal creams  53 (26%) 61 (30%) 92 (45%) 
Traditional African Medicines 47 (23%) 41 (20%) 118 (57%) 
Homeopathy  39 (19%) 42 (20%) 118 (57%) 
Natural Health Supplements  21 (10%) 55 (27%) 130 (63%) 
Traditional Indian Medicines  18 (9%) 35 (17%) 153 (74%) 
Oral Herbal Medicines  13 (6%) 32 (16%) 161 (78%) 
Acupuncture  8 (4%) 79 (38%) 118 (57%) 
Chinese Herbal Medicines  6 (3%) 36 (17%) 164 (80%) 
Reflexology  7 (3%) 67 (33%) 132 (64%) 
Reiki 2 (1%) 44 (21%) 160 (78%) 
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mostly products also containing omega-3 and zinc. Aromatherapy, herbal creams, traditional African-medicines and 
homeopathy were amongst the most frequently used. Percentages are reflected in Table 3. 
Regarding efficacy, 59(45%) CAM-users reported “no improvement”, 32(24%) reported “some improvement” and 
32(24%) felt “a definite improvement”. Nine (7%) were “uncertain of benefit”. Three did not respond. 
CAM was used together with conventionally-prescribed medicines in 63 patients (52%) and 29(24%) reported 
predominantly using CAM over conventionally-prescribed medicines. A few patients (6%) were rarely able to use 
either regularly. Fourteen did not respond. 
 
Familiarity with CAM  
 
Despite extensive CAM-use in this study, a considerable number of people were unfamiliar with CAM. 
Unfamiliarity was reported with Chinese herbal medicines (CHM) (80%), oral herbal medicines (78%), Reiki (78%) 
and traditional Indian-medicines (74%). More than half had no knowledge of traditional African-medicines (57%),  
 
homeopathy (57%), acupuncture (57%), natural health supplements (63%) and reflexology (64%). Although 
comparatively smaller, 45% and 41% were unfamiliar with herbal creams and aromatherapy oils respectively. The 
proportion of patients unfamiliar with vitamins (35%) was equal to those who used vitamins for AE (35%).  
 
Reasons for CAM-use  
 
Patients were questioned as to their reasons for using CAM when prescribed conventional-medicines. Table 4 
provides a summary of reasons and attitudes towards CAM. 
 
Table 4: The general recommendations and reasons for CAM use amongst 135 patients who have reported 
using/previously using CAM 
Patient CAM USE INDEX Number/Proportion 
of Patients (n= 135) 
RECOMMENDATIONS FOR CAM USE 
It was recommended to me by family/friends  54 (42%) 
I read about it in the media 30 (23%) 
My GP recommended it to me  15 (12%) 
The pharmacist recommended it to me  6 (5%) 
The paediatrician recommended it to me  2 (2%) 
REASONS FOR CAM USE 
They are more natural 46 (35%) 
I find that they are safer than conventional medicines  36 (28%) 
They have less side effects 36 (28%) 
The effect is better when I combine it with the dermatologist’s medicines  15 (12%) 
It is a more holistic healthcare 14 (11%) 
 
 
Disclosure of CAM-use  
 
On investigating disclosure of CAM-use, 53(41%) said their dermatologist “was aware”, 75(59%) said their 
dermatologist “was unaware” and 7(5%) did not respond. The common reasons for non-disclosure were “the 
dermatologist did not ask about other medicine usage” (48%); 33% said “it was not necessary for their dermatologist to 
know”.  
 
Discussion 
 
Several studies have demonstrated that among dermatological diseases where patients explore CAM, AE is the 
most prevalent (Hughes et al., 2007; Jensen, 1990; Johnston et al., 2003; Kim et al., 2013; Simpson et al., 2003). Only a 
few studies address the prevalence of AE in SA (Todd, 2014). Prevalence was reported amongst 13-14-year-old school 
children in Cape Town in a Phase One and Phase Three Follow-up International Study of Asthma and Allergies in 
Childhood (ISAAC) which demonstrated an increased one-year prevalence of AE from 8.3%-13.3% (Todd, 2014). 
Despite this, no data on CAM-use in AE was found in Africa. Our study determined the prevalence/extent of CAM-use 
and the determinants of use among AE-patients in central Durban.   
The 100% response rate is strength of this study and a reflection of keen interest in CAM amongst AE-
sufferers. We found a 66% current/previous use of CAMs which was similar to a Korean study (69%) (Kim et al., 
2013) and moderately higher than studies in Norway (51%) (Jensen, 1990), UK (46%) (Johnston et al., 2003), Ireland  
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(43%) (Hughes et al., 2007) and US (50%) (Simpson et al., 2003). The sample size in this study (n=206) was 
comparable to the Korean study (n=254) and larger than studies in UK (n=100), US (n=70) and Ireland (n=80). 
 
Demographics 
 
The racial distribution in this study represents the demographics of Durban where Blacks form the largest 
ethnic group (87%). Although an ethnic minority in SA, the largest Indian population resides in Durban (7.4%), 
followed by Whites (4.2%), Coloured (1.4%) and 0.3% other races. Indians explored CAM the most (78%), similar to a 
Leicester-study where Indians, also an ethnic minority, used CAM more frequently, also mostly through 
recommendations from family/friends (Johnston et al., 2003). A local study among an Indian community also reflected 
substantial CAM-use (Singh et al., 2004). Indian communities, traditionally close-knit with extended family and strong 
cultural influences, could be the reason for this. Other studies also reported recommendation by family/friends as the 
most common reason for trying CAM (Hughes et al., 2007; Johnston et al., 2003; Kim et al., 2013). Other influences 
were the media (23%) which were similar to the Korean study (38%) (Kim et al., 2013). Mass media was also a main 
information source for CAM in a Norway study (Jensen, 1990). Less media influence was reported in Leicester (6%) 
and Ireland (3%) (Hughes et al., 2007; Johnston et al., 2003).  
Religion was a significant predictor of CAM-use and Muslims were more frequent users than other religions. 
The types of CAMs explored by many Muslims were based on medicine prescribed in Islamic religious texts or 
stemming from cultural practices e.g. cupping, Unani-Tibb, Ayurveda, Hakim-medicines (traditional remedies from 
India and Islamic countries) (WHO, 2005).  
A higher percentage (17%) of conventional healthcare practitioners (12% GPs, 5% pharmacists) recommended 
CAM to patients compared to Leicester (6%) and Korea (10%) (Johnston et al., 2003; Kim et al., 2013). None reported 
recommendations by dermatologists. We found that some GPs also practice complementary therapies e.g. Unani-Tibb 
and Ayurveda and may hold dual registrations with SA Professional Councils. In 2000, the Health Product Association 
(HPA) of manufacturers, importers and distributors of complementary medicines and health products, estimated that 
50% turnover in CAM occurred in pharmacies and 2500 pharmacies stocked complementary medicines (Gqaleni et al., 
2007), making it imperative for pharmacists, often the first treatment source, to know the evidence regarding CAMs’ 
efficacy.  
 
Reasons for CAM-use 
  
 Many believed CAMs are “more natural” (35%), “safer than conventional-medicines” (28%), “have less side-
effects” (28%) and “part of a holistic healthcare approach” (11%). 12% reported better effect when combined with 
conventionally-prescribed medicines and 52% said they used CAM this way. None reported exclusive CAM-use which 
is apparent since patients were recruited while seeking conventional treatment. CAM’s role is seen to be mainly 
complementary and not as an alternative to conventional medicines for majority of patients who use them. This 
combined use poses potential for confusion in attribution of therapeutic benefits, side-effects, drug-interactions and 
non-compliance with prescribed-conventional therapy.  
The perception of CAM being natural, safe and without side-effects is important to address amongst the 
general population. There are thousands of CAM products on sale that have never been tested for safety, quality or 
efficacy. This has been recognised and SA legislation was amended in November 2013 providing for the stepwise 
registration of all complementary medicines based on safety, quality and efficacy. New labelling restrictions and their 
manufacture in a registered facility to progressively meet good manufacturing practice (GMP) requirements, have been 
applied to all unregistered complementary medicines (Medicines Control Council, 2013). As full application for all 
products will take much time, thousands of products are still sold without any proof of validity. Although not directly 
questioned about steroid-phobia, responses from open-ended questions in the questionnaire with regards to reasons for 
CAM use, showed that it is a dominant driver towards CAM-use. Many demonstrated reservations and reluctance on 
steroid-use, expressing their need for “something mild”, “not wanting to become dependent on steroids” and 
“concerned about the side-effects of steroids”.   
It was unexpected to find no significant difference between household incomes and CAM use. However, 
despite this, it is interesting to note that it was patients with higher monthly-household incomes (R5000-R20000) that 
were more frequent CAM-users. This is possibly due to high costs making CAM unaffordable to the poorer population 
who are able to receive free conventional treatment. This is consistent with trends in several countries showing positive 
association between socio-economic advantage and AE and that children with higher socio-economic backgrounds are 
more affected with AE than those from poorer families (Medicines Control Council, 2013; Werner et al., 2002). Indians 
in central Durban, the largest concentration of Indians living outside the Indian subcontinent, were the more frequent 
CAM-users in this study and fall within the higher income category compared to Blacks and Coloureds (Medicines 
Control Council, 2013). 
Demographics of age, gender and education level were not significant predictors of CAM-use and were not 
reported as significant in other studies either (Hughes et al., 2007; Jensen, 1990; Johnston et al., 2003; Kim et al., 2013; 
Simpson et al., 2003). 
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CAM Types 
 
Frequently explored CAMs were vitamins (35%), aromatherapy oils (27%), herbal creams (26%), traditional 
African-Medicines (23%) and homeopathy (19%). Vitamins were mostly used for children for general well-being and 
less specifically for AE. Vitamins and herbal creams were also most commonly used in a US-study (Simpson et al., 
2003). Herbal medicines were frequently used in Norway (19%), UK (26%) and Ireland (41%). These were 
uncategorised and assumed to incorporate topical and oral treatment (Hughes et al., 2007; Jensen, 1990; Johnston et al., 
2003). In this study and the US-study, topical herbal preparations were more frequently used than oral preparations. 
Homeopathy demonstrated popularity in our study (19%) and in Norway (34%), UK (22%) and Ireland (24%). Health 
food preparations/health supplements were used amongst 10% of population in this study compared to 18% in the 
Norway study and 17% in the Korean study. The Health Products Association of South Africa (HPA) estimated that 
only 20% of turnover in complementary medicine occurred in health food stores in SA (Gqaleni et al., 2007).  
Herbal Medicines (CHM) (27%) and oriental-medicines (26%) proved popular in UK and Korea (Johnston et 
al., 2003). In contrast, this study found only 3% CHM use and 80% reported unfamiliarity with CHM; evidently due to  
 
the small Chinese population in central Durban (as reflected in our study sample). Although SA has a large Chinese 
population compared to other African countries, the majority reside in other cities (Park, 2009). 
In this study, 27% used aromatherapy oils. Other studies have not reported aromatherapy use. The Korean 
study mentioned bath therapy use by 21% but with no details. Although many CAM-users were Indian, traditional 
Indian-medicines were not frequently used in this study (9%) or the Leicester-study (12%). This is unexpected 
considering the large number of Indians in the study sample. It has been reported that there are various barriers that 
hinder the progression of ayuverda in SA which include the difficulty of practitioners acquiring practice numbers which 
will allow them to be on board with medical aid schemes and the pending wait for proper regulation of ayuverda in SA 
(Lalbahadar, 2013)  
Traditional African-medicines were used by 23%. We found no studies on traditional African-medicine use in 
dermatological diseases. A SA-national household survey revealed low traditional healer use (1,2%), predominantly by 
the poor, unemployed rural community (Nxumalo et al., 2011). Another SA study which investigated the prevalence of 
TM and CAM-use in the general population, showed TM decline but increased CAM-use (Peltzer, 2009).  
We found that CAM-users were long-time AE-sufferers compared to non-users. This relationship of disease 
duration and CAM-use is consistent with a European-study (Jensen, 1990), re-affirming the lack of satisfaction patients 
experience from conventional medicine driving them to seek alternative treatment. 
To date, no CAMs have shown unequivocal evidence of efficacy for AE as confirmed in an overview of SRs of 
controlled trials including CAMs frequently used in our study e.g. vitamins and homeopathy (Thandar et al., 2016). The 
conclusion from 11 RCTs on vitamins found no benefit. Studies were small and of poor quality. A positive effect in 
two fish-oil studies suggested that better designed studies might be justified (Bath-Hextall, Jenkinson, Humphreys, & 
Williams, 2012). The SR reported that although not possible to conclude that all vitamins studied are ineffective, 
absence of evidence prevents them from being recommended clinically (Bath-Hextall et al., 2012). Considering 
extensive vitamin use in our study, it is important to remember that some pose serious risks at high doses (Bath-Hextall 
et al., 2012). Homeopathy was a popular CAM choice in this study and several others (Ernst, 2000). A recent SR failed 
to show any treatment effect and concluded that homeopathy is not supported by sound evidence (Ernst, 2012).   
Unfamiliarity with most CAMs was evident. A Durban study amongst healthcare workers in HIV/AIDS 
clinics also reflected poor CAM knowledge including traditional African-medicines, therapeutic aromatherapy, 
homeopathy, CHM, acupuncture and ayurvedic treatment amongst others (Mbutho et al., 2012); thus, not surprising 
that patients, predominantly the less educated, have limited CAM knowledge. This is likely due to poor information 
dissemination, lack of education and possible low literacy amongst lower socio-economic patients. Although not 
investigated, CAMs are considered expensive and most are not covered by SA medical schemes. In this study, the poor 
with less access to doctors/specialists are not more reliant on CAM and higher income and education are important 
determinants for CAM-use. CAMs are preferred and more accessible to those with resources to access them.  
The majority (59%) did not disclose CAM-use to their dermatologist. Almost half (48%) said they were not 
asked and 33% thought it was not necessary. Patients are more willing to discuss CAM-use if prompted as seen from 
this study’s overwhelming response with patients eager and comfortable discussing all aspects of CAM-use. In a 
Taiwan study with high non-disclosure rates (77%) among hospital dermatological patients, 58% felt no need to 
disclose use and 25% said they were not asked (Chen & Chang, 2003). Similarly, a study assessing patient-provider 
dialogue about CAM use highlighted barriers in communication between patient and physician including reluctance to 
disclose CAM-use, physicians not asking about CAM-use and patients perceiving that physicians are unwilling to 
discuss CAM (Zhang et al., 2012). These issues could be addressed by educating dermatologists and other healthcare 
professionals regarding the current lack of evidence-based safety and efficacy of frequently used CAMs, enabling them 
to confidently discuss and advise patients.  
 
Limitations 
Patients were recruited consecutively, thus a possible selection bias due to non-randomisation exists. 
However, considering that all patients were amenable to participating, response and volunteer-bias could be refuted. 
The majority were open to discussing all aspects of their CAM experience. Patients were ensured of confidentiality,  
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that responses would not be disclosed to their practitioner, documented in their files nor have any impact on their 
clinical care. Results cannot be generalised to another city or SA considering differing demographics per city or 
province.  
There was a small representation of White patients as fewer attend KEH which predominantly services 
patients of poor socio-economic backgrounds. Although recruitment also occurred in five private dermatological 
practices within central Durban, it was found that fewer White patients attend these practices. The dermatologists in 
these practices were Indian (4) and Black (1). It is likely that White patients frequently consult White dermatologists, 
practicing outside central Durban. A random selection of private practices may provide a better representation of 
patients across central Durban rather than the purposive sampling method used. We could not ascertain any association 
between severity and CAM-use as a disease severity assessment was not done. For patients attending KEH, a referral 
hospital, it was assumed that severity was moderate to severe.  
 
Implications in terms of Treatment for AE within the South African context  
 
The value of this study in terms of implications especially with respect to therapy of patients with AE in 
Durban, SA cannot be underestimated. For healthcare professionals treating AE, the cornerstone of therapy in terms of 
evidence is still topical steroids. Topical steroids are first line, maintenance and use as adjuncts to second line therapies 
in recalcitrant cases. The fact that the majority of CAM users in this study do so as they are searching for something 
“more natural” or “less toxic” or are steroid phobic is of concern as they are likely to compromise their outcome by 
either mixing therapies or abandoning topical steroids for CAM. The study also underscores how poor the conversation 
is surrounding CAM between patients and caregivers; hence educating patients on the utility of conventional 
medications versus that of CAM is one of the major lessons of this work. In the absence of education, the outcome for 
such a chronic condition will always be poor, patients will continue to search for alternatives which may not be 
efficacious and perpetuate a vicious cycle. 
 
Recommendations 
 
The results from this study reflect practices of patients in central Durban, Kwa-Zulu Natal. It would be 
necessary for similar studies to be conducted in other regions of Kwa-Zulu Natal and in other provinces to determine 
regional differences and ascertain if there is a similar trend amongst all patients in South Africa.  
 
Conclusion 
 
We found that 66% of our sample had used CAMs and that race, religion and duration of AE were predictors 
of use. Vitamins, aromatherapy oils, herbal creams, traditional African-medicines and homeopathy were the most 
frequently explored CAMs. The majority of patients had not disclosed their CAM-use to their dermatologist. We 
believe ours is the first African study to provide this information within the context of AE. Dermatologists, 
paediatricians, general practitioners (GPs), pharmacists and CAM practitioners that treat patients for AE need to be 
conversant with the various CAMs explored as this may influence the patient’s overall clinical outcome.  
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